Latest News and Press Releases

aTyr Pharma Announces Last Patient Visit in Phase 3 EFZO-FIT™ Study of Efzofitimod in Patients with Pulmonary Sarcoidosis

Podcast dedicated to rare disease sarcoidosis hits 100,000 downloads.

FSR Early Career Fellowship Grant is designed to support early-career investigators in sarcoidosis.

FSR Launches New and Improved Patient Registry

Mark Mallozzi, MD, MPH has been selected to receive the 2025 ATS/FSR Partner Grant.

FSR Global Virtual Sarcoidosis Summit - June 28-29 - is the world’s largest online sarcoidosis event.

Coalition to Transform Clinical Trial Engagement (CTCTE) announces launch of Champions for Change – Paid Time Off (PTO) Initiative.

aTyr Pharma Presents Three Posters on Efzofitimod at the American Thoracic Society (ATS) 2025 International Conference

FSR announces the appointment of four new members to its Board of Directors.

aTyr Pharma Announces First Quarter 2025 Results and Provides Corporate Update